Internal Medicine, Medical Oncology · Detroit, MI
NPI
1033156534
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
2799 W Grand Blvd
Detroit, MI, 48202
Phone (800) 653-6568
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
835 services
Medicare patients, 2024
131
Average age 74
Drug cost, 2024
$3.5M
502 prescriptions
Company payments, 2025
$85K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shirish M Gadgeel was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 130 times for 76 patients. In total Shirish M Gadgeel billed 835 services in 19 codes, and Medicare paid $55K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-05-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 130 | 76 | $13.12 | $1,705 |
| 99215 Office E&M - Established | Office | 126 | 69 | $111.59 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 76 | 39 | $12.77 | $971 |
| 99215 Office E&M - Established | Facility | 74 | 36 | $110.91 | $8,208 |
| 99205 Office E&M - New | Office | 15 | 15 | $146.65 | $2,200 |
By year: 2022 $36K for 341 services; 2023 $40K for 457 services; 2024 $55K for 835 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shirish M Gadgeel prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 90 prescriptions and refills. In total Shirish M Gadgeel wrote 502 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 90 | 90 | 15 | $1.4M |
| Alecensa Alectinib Hcl | 38 | 38 | Under 11 | $639K |
| Olanzapine Generic | 27 | 27 | 11 | $41.77 |
| Dexamethasone Generic | 27 | 27 | 13 | $121 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 24 | 24 | Under 11 | $765 |
| Ondansetron Odt Ondansetron | 22 | 22 | 19 | $313 |
| Tabrecta Capmatinib Hydrochloride | 21 | 21 | Under 11 | $298K |
| Retevmo Selpercatinib | 21 | 21 | Under 11 | $429K |
| Eliquis Apixaban | 18 | 28 | Under 11 | $15K |
| Lumakras Sotorasib | 15 | 15 | Under 11 | $301K |
| Rozlytrek Entrectinib | 11 | 11 | Under 11 | $150K |
| Potassium Chloride Generic | 11 | 17 | Under 11 | $259 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 11 | 12 | 11 | $106 |
Brand drugs: 241 claims; generic drugs: 261 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shirish M Gadgeel $85K ($78K in general payments such as food, travel and fees and $7,147 for research) from 25 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $16K.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $16K |
| Pfizer Inc. PFE | 12 | $13K |
| F. Hoffmann-La Roche AG ROG.SW | 9 | $7,202 |
| Daiichi Sankyo Inc. 4568.T | 4 | $7,055 |
| Abbvie Inc. ABBV | 5 | $5,497 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $5,033 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $4,291 |
| GlaxoSmithKline, LLC. GSK | 5 | $3,968 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $3,852 |
| Janssen Biotech, Inc. JNJ | 4 | $3,541 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.